Rhoen Klinikum AG
XETRA:RHK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhoen Klinikum AG
XETRA:RHK
|
DE |
|
AXA SA
PAR:CS
|
FR |
|
Atlas Salt Inc
XTSX:SALT
|
CA |
|
J
|
JBT Marel Corp
DUS:JBT
|
US |
|
Ichor Holdings Ltd
NASDAQ:ICHR
|
US |
Wall St Price Targets
RHK Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for RHK is 14.45 EUR with a low forecast of 12.63 EUR and a high forecast of 16.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RHK's stock price target?
Price Target
14.45
EUR
According to Wall Street analysts, the average 1-year price target for RHK is 14.45 EUR with a low forecast of 12.63 EUR and a high forecast of 16.8 EUR.
What is the Revenue forecast for Rhoen Klinikum AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Rhoen Klinikum AG?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 5 years is -4%.
What is the Operating Income forecast for Rhoen Klinikum AG?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 5 years is 21%.
What is the Pre-Tax Income forecast for Rhoen Klinikum AG?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -7%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Rhoen Klinikum AG?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 3 years is 20%.
